In a report released today, Alan Carr from Needham maintained a Buy rating on Iterum Therapeutics (ITRM – Research Report),
Tag: NASDAQ:ITRM
Iterum Therapeutics Plc (ITRM) Gets a Buy Rating from Needham
In a report released yesterday, Alan Carr from Needham maintained a Buy rating on Iterum Therapeutics Plc (ITRM – Research
Iterum Therapeutics Plc (ITRM) Gets a Buy Rating from Needham
In a report released today, Alan Carr from Needham maintained a Buy rating on Iterum Therapeutics Plc (ITRM – Research